Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53 wild–type JVM-2 But Not Towards p53 mutated BJAB Leukemic Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|21|2712-2722

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.21, 2013-07, pp. : 2712-2722

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 2, 2018-01 ,pp. : 173-183

Bentham Science Publishers

Access to resources Recommend Favorite

Experimental Research on Wild-type p53 Plasmid Transfected into Retinoblastoma Cells and Tissues using an Ultrasound Microbubble Intensifier

By Luo J   Zhou X   Diao L   Wang Z  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1005-1015

Field House Publishing

Access to resources Recommend Favorite

Synergistic Cytotoxic Activity of Recombinant TRAIL Plus the Non-Genotoxic Activator of the p53 Pathway Nutlin-3 in Acute Myeloid Leukemia Cells

By  

Current Drug Metabolism, Vol. 8, Iss. 4, 2007-05 ,pp. : 395-403

Bentham Science Publishers

Access to resources Recommend Favorite

Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein

By Wesierska-Gadek Józefa   Schmid Gerald  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 23-38

Informa Healthcare

Access to resources Recommend Favorite

Cellular Distribution of Tumour Suppressor Protein p53 and High-risk Human Papillomavirus (HPV)-18 E6 Fusion Protein in Wild-type p53 Cell Lines

By Sun L   Zhang G   Li Z   Lei T   Huang C   Song T   Si L  

The Journal of International Medical Research, Vol. 36, Iss. 5, 2008-09 ,pp. : 1015-1021

Field House Publishing

Access to resources Recommend Favorite